gene editing
ASH: CRISPR, Vertex’ CTX001 hits the mark in red cell disorders
Phil Taylor
beta thalassaemia, CRISPR Therapeutics, CRISPR/Cas9, gene editing, sickle cell disease, Vertex Pharma
0 Comment
CRISPR pioneers Doudna and Charpentier claim Nobel chemistry prize
Phil Taylor
CRISPR/Cas9, gene editing, Nobel prize
0 Comment
News/ News/ News/ Patients/ R&D
Stem cell transplant eradicates HIV in second patient
Phil Taylor
gene editing, HIV, infectious disease, stem cell therapy
0 Comment
First patient dosed in trial of Allergan/Editas’ CRISPR blindness drug
Phil Taylor
Allergan, blindness, CRISPR/Cas9, Editas, gene editing, Leber’s Congenital Amaurosis, ophthalmology
0 Comment
Partner Content/ Partner content/ Press releases
4th Annual Genome Editing USA Congress
Bradley Copeman
cas9, CRISPR, gene editing, Genome Editing, Genome Engineering
0 Comment
2 days, 350+ end users, 80+ case studies
News/ News/ News/ Patients/ R&D
CRISPR trials yield encouraging data in blood disorders
Phil Taylor
beta thalassaemia, CRISPR Therapeutics, CRISPR/Cas9, gene editing, sickle cell disease, Vertex Pharma
0 Comment
Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal
Phil Taylor
bluebird bio, gene editing, genetic, Haematology, haemophilia, Novo Nordisk
0 Comment
Broad, MilliporeSigma issue call to make access to CRISPR freer
Phil Taylor
Broad Institute, CRISPR/Cas9, gene editing, MilliporeSigma
0 Comment